Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2003
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1335987A2 Modified vaccinia ankara virus variant
08/20/2003EP1335972A2 Tolerizing allografts of pluripotent stem cells
08/20/2003EP1335933A2 Pna analogues
08/20/2003EP1335931A2 Derivatisation of proteins in aqueous solution
08/20/2003EP1335924A2 Ethers of 7-desmethylrapamycin for use in immunosuppression
08/20/2003EP1335923A2 Condensed pyridoindole derivatives
08/20/2003EP1335917A2 Condensed pyridoindole derivatives
08/20/2003EP1335741A2 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE
08/20/2003EP1335740A1 Method and preparations having effect against allergic symptoms
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1212326A4 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1093381B1 Antigenic peptides derived from telomerase
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP0861091B1 Immunotoxin containing a disulfide-stabilized antibody fragment
08/20/2003EP0799040B1 Trisubstituted thioxanthines
08/20/2003EP0783311B1 Synthetic ganglioside derivatives
08/20/2003CN1437605A Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/20/2003CN1437599A Tryasolyl tropane derivatives for therapy
08/20/2003CN1437591A Compounds and methods for modulation of estrogen receptors
08/20/2003CN1437585A Method and compositions utilizing quinazolinones
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives
08/20/2003CN1437575A Aminomethyl-phenyl-cyclohexanone derivatives
08/20/2003CN1437482A Recombinant or purified polyclonal antibodies for treating allergy
08/20/2003CN1437481A QS-21 and IL-12 as an adjuvant combination
08/20/2003CN1437479A Recombinant intracellular pathogen vaccines and methods for use
08/20/2003CN1437476A Optimized minigenes and peptides encoded thereby
08/20/2003CN1437463A System and method for treating a mucosal surface
08/20/2003CN1436847A Chinese human thymosin-alpha source and its prepn
08/20/2003CN1436542A Recipe of medicine for treating urticaria
08/20/2003CN1436537A Oral liquid with hyaluronic acid as effective component
08/20/2003CN1436536A Effervescent tablet with hyaluronic acid as effective component
08/20/2003CN1118476C Antiviral protease inhibitors
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/20/2003CN1118458C Pyrimidinyl derivatives as interleukin inhibitors
08/20/2003CN1118287C Health-care medicine
08/19/2003WO2003070947A1 Apoptosis promoter and inhibitor interacting with cgi-94 and method of screening the same
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608197 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
08/19/2003US6608179 Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80)
08/19/2003US6608177 Mutation of serine replaced with cysteine; use as anti-HIV, anti-allergic or anti- inflammatory agents
08/19/2003US6608107 Administering gossypol; kits to treat patients
08/19/2003US6608105 For therapy and prophylaxis of diseases such as cachexia attributed to cancer or infections, rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus, rejection during bone marrow transplantation
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608083 Treatment and/or prophylaxis of convulsive disorders, renal disorders, urinary incontinence, ocular inflammation, eating disorders, inflammatory pain, allergic rhinitis, psoriasis,neurodegenerative disorders, Huntington's disease,
08/19/2003US6608077 Il-8 receptor antagonists
08/19/2003US6608072 Inhibiting production of soluble tumor necrosis factor or reducing inflammation
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6608063 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes
08/19/2003US6608057 Compounds useful as reversible inhibitors of cathepsin S
08/19/2003US6608044 Inhibition of TNF activity
08/19/2003US6608032 Medicinal compositions
08/19/2003US6608030 Inhibitor of cathepsin S based upon peptide sequence which comprises at least about 2-20 consecutive residues from preferred invariant chain cleavage site of cathepsin S, spanning from residue 68 to residue 90 of specified sequence
08/19/2003US6607897 Reptile venom polypeptide for use in reduction of complement activity
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607723 Removing preformed antibodies to various identified carbohydrate xenoantigens from recipient's circulation prior to transplantation by extracorporeal perfusion
08/19/2003US6607722 Methods for inducing the differentiation of monocytes into functional dendritic cells
08/19/2003CA2433180A1 Apoptosis promoting and suppressing substances interacting with cgi-94, and methods for screening the same
08/19/2003CA2138258C Synthetic peptides for the treatment of myasthenia gravis
08/19/2003CA2111083C Novel peptides, their preparation and use
08/19/2003CA2099867C 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
08/19/2003CA2099061C Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
08/19/2003CA2095854C Mycobacterium vaccae in the treatment of uveitis
08/19/2003CA2085347C Novel cyclic aminophenylacetic acid derivative, production therof, and immune response modulator containing the same as active ingredient
08/19/2003CA2079376C (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/19/2003CA2079375C (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/14/2003WO2003067221A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003WO2003066806A2 Therapeutic use of aziridino compounds
08/14/2003WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency
08/14/2003WO2003066656A1 Crystalline complexes of fluticasone 2-furoate
08/14/2003WO2003066655A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
08/14/2003WO2003066649A1 Immunostimulatory, covalently lipidated oligonucleotides
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066635A1 Piperidine derivatives
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins
08/14/2003WO2003066618A1 Cytoprotective benzofuran derivatives
08/14/2003WO2003066604A2 Novel aryl- and heteroarylpiperazines
08/14/2003WO2003066593A2 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl )-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-methyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/14/2003WO2003066591A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066590A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066589A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
08/14/2003WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
08/14/2003WO2003066095A2 MODULATING TOLERANCE BY MODULATING FcϜRIIB RECEPTOR SIGNALLING
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
1 ... 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 ... 1172